Immunity for Health

IfH Symposium: Innovations in Antibody-Based Biologics

11 Jun 2026 | Landmark Building, UZ Brussels, Belgium

Register
Register
Register

Thursday, 11 June 2026 | 14:00 - 14:20

Bringing HER2 imaging to the clinic: from discovery to Phase 2b validation - Tony Lahoutte & Karine Clauwaert, UZ Brussels - Abscint

The speakers will share the development of ABSCINT’s HER2-targeted imaging platform, from concept to Phase 2b clinical validation in the HERMIA study. The results support its potential to reshape how HER2 expression is assessed and used in treatment decision-making.

2 speakers

  • CEO

    ABSCINT

  • Head of the department of nuclear medicine

    Vrije Universiteit Brussel